Avalon Pharma Signs Memorandum of Understanding with Sadan Cancer Charity Association to Advance Health Awareness and Community Impact

Avalon Pharma is pleased to announce the signing of a Memorandum of Understanding (MoU) with the Saudi Cancer Charity Association (Sadan), reinforcing a shared commitment to supporting community initiatives, promoting health awareness, and developing human capabilities to create sustainable social impact.

The agreement was signed on behalf of Avalon Pharma by Mr. Hamoud Al-Anazi, Chief Executive Officer of Administrative Affairs, while Mr. Moqbel bin Mohammed Al-Suraih, Executive Director, represented Sadan Association.

The partnership will focus on several areas of collaboration, including the implementation of training programs, the provision of advisory support in human resources and project management, the organization of awareness campaigns and community initiatives, and the delivery of early breast cancer screening programs for Avalon Pharma employees and their families.

This collaboration reflects Avalon Pharma’s belief in the importance of strengthening partnerships between the private and non-profit sectors as a key driver of sustainable development and social responsibility.

Through such initiatives, Avalon Pharma continues to contribute to the achievement of Saudi Vision 2030 by supporting community well-being, advancing health awareness, and fostering meaningful social impact.

#Avalon_Pharma
#Sadan
#SocialResponsibility
#CancerAwareness